Lemborexant Treatment of Insomnia Linked to Epilepsy
The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.
- EligibilityCriteria: Inclusion Criteria:  Sleep-related focal epilepsy Contraception  Exclusion Criteria:  Changes in antiseizure medication 1 month before study protocol or during study protocol Concomitant medications per SUNRISE1 Individuals with hepatic impairment Female participants who are pregnant or breastfeeding Individuals with compromised respiratory function Individuals with a history of complex sleep-related behaviour Individuals with rare hereditary diseases of galactose intolerance such as galactosemia or glucose-galactose malabsorption Individuals with a history of dependence or tolerance - abuse, dependence, rebound insomnia Individuals with psychiatric disorders with abnormal thinking and behavioural changes, depression, or suicidal ideation Individuals with a diagnosis of narcolepsy - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - StdAgeList: Adult, Older Adult